Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25


Managing Advanced HIV Disease in a Public Health Approach.

Ford N, Meintjes G, Calmy A, Bygrave H, Migone C, Vitoria M, Penazzato M, Vojnov L, Doherty M; Guideline Development Group for Managing Advanced HIV Disease and Rapid Initiation of Antiretroviral Therapy .

Clin Infect Dis. 2018 Mar 4;66(suppl_2):S106-SS110. doi: 10.1093/cid/cix1139.


Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe.

Ndlovu Z, Fajardo E, Mbofana E, Maparo T, Garone D, Metcalf C, Bygrave H, Kao K, Zinyowera S.

PLoS One. 2018 Mar 2;13(3):e0193577. doi: 10.1371/journal.pone.0193577. eCollection 2018.


"We are part of a family". Benefits and limitations of community ART groups (CAGs) in Thyolo, Malawi: a qualitative study.

Pellecchia U, Baert S, Nundwe S, Bwanali A, Zamadenga B, Metcalf CA, Bygrave H, Daho S, Ohler L, Chibwandira B, Kanyimbo K.

J Int AIDS Soc. 2017 Mar 28;20(1):21374. doi: 10.7448/IAS.20.1.21374.


Reimagining HIV service delivery: the role of differentiated care from prevention to suppression.

Grimsrud A, Bygrave H, Doherty M, Ehrenkranz P, Ellman T, Ferris R, Ford N, Killingo B, Mabote L, Mansell T, Reinisch A, Zulu I, Bekker LG.

J Int AIDS Soc. 2016 Dec 1;19(1):21484. doi: 10.7448/IAS.19.1.21484. eCollection 2016. No abstract available.


"They just come, pick and go." The Acceptability of Integrated Medication Adherence Clubs for HIV and Non Communicable Disease (NCD) Patients in Kibera, Kenya.

Venables E, Edwards JK, Baert S, Etienne W, Khabala K, Bygrave H.

PLoS One. 2016 Oct 20;11(10):e0164634. doi: 10.1371/journal.pone.0164634. eCollection 2016.


Sustaining the future of HIV counselling to reach 90-90-90: a regional country analysis.

Bemelmans M, Baert S, Negussie E, Bygrave H, Biot M, Jamet C, Ellman T, Banda A, van den Akker T, Ford N.

J Int AIDS Soc. 2016 May 13;19(1):20751. doi: 10.7448/IAS.19.1.20751. eCollection 2016. Review.


Hit me with your best shot: dolutegravir - a space in the next WHO guidelines?

Cohn J, Bekker LG, Bygrave H, Calmy A.

AIDS. 2015 Oct 23;29(16):2067-70. doi: 10.1097/QAD.0000000000000813. No abstract available.


Designing text-messaging (SMS) in HIV programs: ethics-framed recommendations from the field.

Pérez GM, Hwang B, Bygrave H, Venables E.

Pan Afr Med J. 2015 Jul 16;21:201. doi: 10.11604/pamj.2015.21.201.6844. eCollection 2015.


HIV with non-communicable diseases in primary care in Kibera, Nairobi, Kenya: characteristics and outcomes 2010-2013.

Edwards JK, Bygrave H, Van den Bergh R, Kizito W, Cheti E, Kosgei RJ, Sobry A, Vandenbulcke A, Vakil SN, Reid T.

Trans R Soc Trop Med Hyg. 2015 Jul;109(7):440-6. doi: 10.1093/trstmh/trv038. Epub 2015 May 21.


Reframing HIV care: putting people at the centre of antiretroviral delivery.

Duncombe C, Rosenblum S, Hellmann N, Holmes C, Wilkinson L, Biot M, Bygrave H, Hoos D, Garnett G.

Trop Med Int Health. 2015 Apr;20(4):430-47. doi: 10.1111/tmi.12460. Epub 2015 Feb 16.


The future role of CD4 cell count for monitoring antiretroviral therapy.

Ford N, Meintjes G, Pozniak A, Bygrave H, Hill A, Peter T, Davies MA, Grinsztejn B, Calmy A, Kumarasamy N, Phanuphak P, deBeaudrap P, Vitoria M, Doherty M, Stevens W, Siberry GK.

Lancet Infect Dis. 2015 Feb;15(2):241-7. doi: 10.1016/S1473-3099(14)70896-5. Epub 2014 Nov 19. Review.


Opportunities to improve storage and transportation of blood specimens for CD4 testing in a rural district in Zimbabwe using BD vacutainer CD4 stabilization tubes: a stability and diagnostic accuracy study.

Fajardo E, Metcalf C, Mbofana E, van Vyve C, Munyaradzi D, Simons S, Kuhudzayi M, Bygrave H.

BMC Infect Dis. 2014 Oct 22;14:553. doi: 10.1186/s12879-014-0553-9.


Feasibility and benefits of scaling up antiretroviral treatment provision with the 2010 WHO antiretroviral therapy guidelines in rural Lesotho.

Bygrave H, Saranchuk P, Makakole L, Ford N.

Int Health. 2012 Sep;4(3):170-5. doi: 10.1016/j.inhe.2012.06.002.


Pooled HIV-1 viral load testing using dried blood spots to reduce the cost of monitoring antiretroviral treatment in a resource-limited setting.

Pannus P, Fajardo E, Metcalf C, Coulborn RM, Durán LT, Bygrave H, Ellman T, Garone D, Murowa M, Mwenda R, Reid T, Preiser W.

J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):134-7. doi: 10.1097/QAI.0b013e3182a61e63.


Antiretroviral therapy outcomes among adolescents and youth in rural Zimbabwe.

Bygrave H, Mtangirwa J, Ncube K, Ford N, Kranzer K, Munyaradzi D.

PLoS One. 2012;7(12):e52856. doi: 10.1371/journal.pone.0052856. Epub 2012 Dec 20.


Combining UK general practice with international work--who benefits?

Seo HN, Smith C, Pettigrew LM, Dorward J, Bygrave H.

Br J Gen Pract. 2012 Oct;62(603):e726-8. doi: 10.3399/bjgp12X656991. No abstract available.


Challenges and opportunities for the implementation of virological testing in resource-limited settings.

Roberts T, Bygrave H, Fajardo E, Ford N.

J Int AIDS Soc. 2012 Oct 9;15(2):17324. doi: 10.7448/IAS.15.2.17324. Review.


Public health. Getting HIV treatment to the most people.

Lynch S, Ford N, van Cutsem G, Bygrave H, Janssens B, Decroo T, Andrieux-Meyer I, Roberts T, Balkan S, Casas E, Ferreyra C, Bemelmans M, Cohn J, Kahn P, Goemaere E.

Science. 2012 Jul 20;337(6092):298-300. doi: 10.1126/science.1225702. Epub 2012 Jul 12. No abstract available.


Cost and cost-effectiveness of switching from d4T or AZT to a TDF-based first-line regimen in a resource-limited setting in rural Lesotho.

Jouquet G, Bygrave H, Kranzer K, Ford N, Gadot L, Lee J, Hilderbrand K, Goemaere E, Vlahakis N, Trivino L, Makakole L, Cleary S.

J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):e68-74. doi: 10.1097/QAI.0b013e31822a9f8d.


Renal safety of a tenofovir-containing first line regimen: experience from an antiretroviral cohort in rural Lesotho.

Bygrave H, Kranzer K, Hilderbrand K, Jouquet G, Goemaere E, Vlahakis N, Triviño L, Makakole L, Ford N.

PLoS One. 2011 Mar 2;6(3):e17609. doi: 10.1371/journal.pone.0017609.

Supplemental Content

Loading ...
Support Center